Dr. Reddy's Laboratories Ltd. (DRREDDY)
NSE
Closed
Sep 8, 2026
Day's Range
1,144.0052 wk Range
1,101.00Overview - DRREDDY - Dr. Reddy's Laboratories Ltd.
Key Statistics
Valuation
Enterprise Value
975.08B
P/E (Trailing)
‪29.70‬
P/E (Forward)
‪19.86‬
PEG Ratio
‪-0.43‬
Price / Sales (TTM)
‪2.96‬
Price / Book
‪2.55‬
EV / EBITDA
‪17.83‬
Profitability
Gross Margin
‪46.51%‬
Profit Margin
‪9.99%‬
Operating Margin
‪4.25%‬
Return on Assets
‪4.01%‬
Return on Equity
‪8.83%‬
Ownership
Shares Outstanding
832.98M
Float
599.97M
Held by Insiders
‪30.12%‬
Held by Institutions
‪52.50%‬
Price stats
Beta
‪0.24‬
50-Day Avg
‪1,230.96‬
200-Day Avg
‪1,257.33‬
Dividends
Payout Ratio
‪20.14%‬
Frequency
Annual
Analyst Consensus
39 analysts
Average price target
‪₹ 1,265.77‬Market Cap - DRREDDY - Dr. Reddy's Laboratories Ltd.
Peers - DRREDDY - Dr. Reddy's Laboratories Ltd.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on NSE.
Profile Summary - DRREDDY - Dr. Reddy's Laboratories Ltd.
About
Dr. Reddy's Laboratories Ltd. is a globally recognized pharmaceutical company specializing in the manufacturing and distribution of a wide array of therapeutic substances and active pharmaceutical ingredients (APIs). Established in 1984 and headquartered in Hyderabad, India, the company plays a significant role in the…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
